Search results

Find out which guidance and quality standards are awaiting development

View a complete list of all our guidance, NICE advice and quality standards currently in development

See a complete list of all our guidance and quality standards currently open for consultation

How to register with us as a diagnostic technologies stakeholder.

How to register with us as a medical technologies stakeholder.

NICE is committed to involving people who use services, carers and the public in the development of our guidance and other products.

Our recommendations on the use of highly specialised technologies are made by an independent advisory committee

Advises NICE on the formulation of its guidance on the safety and efficacy of interventional procedures.

Biographies for all current members of the diagnostics advisory committee.

Membership details, terms of reference, future meeting dates and past meeting minutes for our 4 technology appraisal committees.

Biographies and registered interests for members of the Technology Appraisal Committee A

Find out more about the NICE technology appraisal advisory committee B members and their registered interests

Evidence-based recommendations on enzyme-linked immunosorbent assay (ELISA) tests for therapeutic monitoring of tumour necrosis factor (TNF)-alpha inhibitors in rheumatoid arthritis. The tests are Promonitor, IDKmonitor, LISA-tracker, RIDASCREEN, MabTrack, and those used by Sanquin Diagnostic Services.

Result type

HealthTech guidance

Published

10 July 2019

Evidence-based recommendations on therapeutic monitoring of tumour necrosis factor (TNF)-alpha inhibitors (LISA-TRACKER, IDKmonitor and Promonitor ELISA kits) in people with Crohn’s disease.

Result type

HealthTech guidance

Published

17 February 2016

Evidence-based recommendations on the My5-FU assay for measuring levels of 5-flurouracil (5-FU) in patients having chemotherapy, to help guide changes to the dose of 5-FU.

Result type

HealthTech guidance

Published

10 December 2014